72 related articles for article (PubMed ID: 25644867)
1. In Vivo UTE-MRI Reveals Positive Effects of Raloxifene on Skeletal-Bound Water in Skeletally Mature Beagle Dogs.
Allen MR; Territo PR; Lin C; Persohn S; Jiang L; Riley AA; McCarthy BP; Newman CL; Burr DB; Hutchins GD
J Bone Miner Res; 2015 Aug; 30(8):1441-4. PubMed ID: 25644867
[TBL] [Abstract][Full Text] [Related]
2. Effects of combination treatment with alendronate and raloxifene on skeletal properties in a beagle dog model.
Allen MR; McNerny E; Aref M; Organ JM; Newman CL; McGowan B; Jang T; Burr DB; Brown DM; Hammond M; Territo PR; Lin C; Persohn S; Jiang L; Riley AA; McCarthy BP; Hutchins GD; Wallace JM
PLoS One; 2017; 12(8):e0181750. PubMed ID: 28793321
[TBL] [Abstract][Full Text] [Related]
3. In vivo reference point indentation reveals positive effects of raloxifene on mechanical properties following 6 months of treatment in skeletally mature beagle dogs.
Aref M; Gallant MA; Organ JM; Wallace JM; Newman CL; Burr DB; Brown DM; Allen MR
Bone; 2013 Oct; 56(2):449-53. PubMed ID: 23871851
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo exposure to calcitonin or raloxifene improves mechanical properties of diseased bone through non-cell mediated mechanisms.
Surowiec RK; Saldivar R; Rai RK; Metzger CE; Jacobson AM; Allen MR; Wallace JM
Bone; 2023 Aug; 173():116805. PubMed ID: 37196853
[TBL] [Abstract][Full Text] [Related]
5. Combining raloxifene and mechanical loading improves bone composition and mechanical properties in a murine model of chronic kidney disease (CKD).
Surowiec RK; Reul ON; Chowdhury NN; Rai RK; Segvich D; Tomaschke AA; Damrath J; Jacobson AM; Allen MR; Wallace JM
Bone; 2024 Jun; 183():117089. PubMed ID: 38575047
[TBL] [Abstract][Full Text] [Related]
6. Raloxifene enhances material-level mechanical properties of femoral cortical and trabecular bone.
Allen MR; Hogan HA; Hobbs WA; Koivuniemi AS; Koivuniemi MC; Burr DB
Endocrinology; 2007 Aug; 148(8):3908-13. PubMed ID: 17478550
[TBL] [Abstract][Full Text] [Related]
7. Assessment of cortical bone with clinical and ultrashort echo time sequences.
Du J; Hermida JC; Diaz E; Corbeil J; Znamirowski R; D'Lima DD; Bydder GM
Magn Reson Med; 2013 Sep; 70(3):697-704. PubMed ID: 23001864
[TBL] [Abstract][Full Text] [Related]
8. Bone cell-independent benefits of raloxifene on the skeleton: a novel mechanism for improving bone material properties.
Gallant MA; Brown DM; Hammond M; Wallace JM; Du J; Deymier-Black AC; Almer JD; Stock SR; Allen MR; Burr DB
Bone; 2014 Apr; 61():191-200. PubMed ID: 24468719
[TBL] [Abstract][Full Text] [Related]
9. Raloxifene enhances peri-implant bone healing in osteoporotic rats.
Ramalho-Ferreira G; Faverani LP; Prado FB; Garcia IR; Okamoto R
Int J Oral Maxillofac Surg; 2015 Jun; 44(6):798-805. PubMed ID: 25813087
[TBL] [Abstract][Full Text] [Related]
10. Structural features underlying raloxifene's biophysical interaction with bone matrix.
Bivi N; Hu H; Chavali B; Chalmers MJ; Reutter CT; Durst GL; Riley A; Sato M; Allen MR; Burr DB; Dodge JA
Bioorg Med Chem; 2016 Feb; 24(4):759-67. PubMed ID: 26795112
[TBL] [Abstract][Full Text] [Related]
11. Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment.
Allen MR; Burr DB
J Bone Miner Res; 2007 Nov; 22(11):1759-65. PubMed ID: 17663638
[TBL] [Abstract][Full Text] [Related]
12. Deuterium nuclear magnetic resonance unambiguously quantifies pore and collagen-bound water in cortical bone.
Ong HH; Wright AC; Wehrli FW
J Bone Miner Res; 2012 Dec; 27(12):2573-81. PubMed ID: 22807107
[TBL] [Abstract][Full Text] [Related]
13. The effects of long-term raloxifene and estradiol treatments on bone in a patient with congenital aromatase deficiency.
Zirilli L; Maffei L; Meunier PJ; Chavassieux P; Carani C; Rochira V
Bone; 2009 Nov; 45(5):827-32. PubMed ID: 19345749
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional accurate detection of lung emphysema in rats using ultra-short and zero echo time MRI.
Bianchi A; Tibiletti M; Kjørstad Å; Birk G; Schad LR; Stierstorfer B; Rasche V; Stiller D
NMR Biomed; 2015 Nov; 28(11):1471-9. PubMed ID: 26403226
[TBL] [Abstract][Full Text] [Related]
15. Selective modification of bone quality by PTH, pamidronate, or raloxifene.
Brennan TC; Rizzoli R; Ammann P
J Bone Miner Res; 2009 May; 24(5):800-8. PubMed ID: 19063681
[TBL] [Abstract][Full Text] [Related]
16. Weighted subtraction in 3D ultrashort echo time (UTE) imaging for visualization of short T2 tissues of the knee.
Lee YH; Kim S; Song HT; Kim I; Suh JS
Acta Radiol; 2014 May; 55(4):454-61. PubMed ID: 23934936
[TBL] [Abstract][Full Text] [Related]
17. Comparing the effects of 17β-oestradiol and the selective oestrogen receptor modulators, raloxifene and tamoxifen, on prepulse inhibition in female rats.
Gogos A; van den Buuse M
Schizophr Res; 2015 Nov; 168(3):634-9. PubMed ID: 25979306
[TBL] [Abstract][Full Text] [Related]
18. New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats.
Ma YL; Bryant HU; Zeng Q; Schmidt A; Hoover J; Cole HW; Yao W; Jee WS; Sato M
Endocrinology; 2003 May; 144(5):2008-15. PubMed ID: 12697709
[TBL] [Abstract][Full Text] [Related]
19. Effect of raloxifene on arthritis and bone mineral density in rats with collagen-induced arthritis.
Hayashi I; Hagino H; Okano T; Enokida M; Teshima R
Calcif Tissue Int; 2011 Feb; 88(2):87-95. PubMed ID: 21140260
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate.
Ettinger B; San Martin J; Crans G; Pavo I
J Bone Miner Res; 2004 May; 19(5):745-51. PubMed ID: 15068497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
